Shire
Shire files for Gaucher drug in Europe
December 1, 2009Sales and Marketing Cerezyme, Gaucher, Shire
Shire has followed up its marketing applications for Gaucher disease treatment velaglucerase alfa in the US and Canada with a …
Shire goes for early approval in Gaucher disease
September 1, 2009Research and Development, Sales and Marketing Gaucher's, Shire
Shire has filed for early US approval of its Gaucher disease drug velaglucerase alfa, as supplies to Genzyme's established rival …
Shire to close small molecule plant
April 14, 2009Manufacturing and Production Shire
Shire Pharmaceuticals is shutting down a US production facility and will outsource the production to contract manufacturers DSM.The measure is …
Shire withdraws ADHD patch filing
March 19, 2009Research and Development, Sales and Marketing Shire
Shire has withdrawn the European marketing application for its Attention Deficit Hyperactivity Disorder (ADHD) patch product Daytrana. The product's active …
Shire acquires ADHD presence in Europe
February 23, 2009Sales and Marketing ADHD, Shire
Shire has bought the global rights for two established treatments for Attention Deficit Hyperactivity Disorder from UCB. The acquisition gives …
Latest content
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical
